Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Fierce Biotech
FDA delays ruling on AstraZeneca drug after negative adcomm vote
The FDA deferred its ruling on AstraZeneca’s camizestrant to review analyses filed after an advisory committee voted against the breast cancer asset.
Nick Paul Taylor
May 27, 2026 4:43am
Niowave starts building $75M plant to boost radioisotope supply
May 26, 2026 8:35am
EU regulator recommends AZ's Etcamah, Novo's Wegovy pill
May 22, 2026 11:58am
AZ, Daiichi's Datroway approved in first-line TNBC
May 22, 2026 11:32am
AbbVie, GSK race up patient reputation leaderboard in the UK
May 22, 2026 9:16am
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
May 22, 2026 8:53am
